Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Drp1/Fis1-mediated mitochondrial fragmentation leads to lysosomal dysfunction in cardiac models of Huntington's disease.

Authors:
A U Joshi A E Ebert B Haileselassie D Mochly-Rosen

J Mol Cell Cardiol 2019 02 11;127:125-133. Epub 2018 Dec 11.

Department of Chemical and Systems Biology, Stanford University School of Medicine, Stanford, CA, United States. Electronic address:

Huntington's disease (HD) is a fatal hereditary neurodegenerative disorder, best known for its clinical triad of progressive motor impairment, cognitive deficits and psychiatric disturbances, is caused by CAG-repeat expansion in exon 1 of Huntingtin (HTT). However, in addition to the neurological disease, mutant HTT (mHTT), which is ubiquitously expressed in all tissues, impairs other organ systems. Not surprisingly, cardiovascular dysautonomia as well as the deterioration of circadian rhythms are among the earliest detectable pathophysiological changes in individuals with HD. Mitochondrial dysfunction in the brain and skeletal muscle in HD has been well documented, as the disease progresses. However, not much is known about mitochondrial abnormalities in the heart. In this study, we describe a role for Drp1/Fis1-mediated excessive mitochondrial fission and dysfunction, associated with lysosomal dysfunction in H9C2 expressing long polyglutamine repeat (Q73) and in human iPSC-derived cardiomyocytes transfected with Q77. Expression of long polyglutamine repeat led to reduced ATP production and mitochondrial fragmentation. We observed an increased accumulation of damaged mitochondria in the lysosome that was coupled with lysosomal dysfunction. Importantly, reducing Drp1/Fis1-mediated mitochondrial damage significantly improved mitochondrial function and cell survival. Finally, reducing Fis1-mediated Drp1 recruitment to the mitochondria, using the selective inhibitor of this interaction, P110, improved mitochondrial structure in the cardiac tissue of R6/2 mice. We suggest that drugs focusing on the central nervous system will not address mitochondrial function across all organs, and therefore will not be a sufficient strategy to treat or slow down HD disease progression.

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.yjmcc.2018.12.004DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6894172PMC
February 2019

Publication Analysis

Top Keywords

lysosomal dysfunction
12
drp1/fis1-mediated mitochondrial
8
polyglutamine repeat
8
huntington's disease
8
improved mitochondrial
8
long polyglutamine
8
mitochondrial function
8
mitochondrial fragmentation
8
mitochondrial
8
disease
5
dysfunction
5
cardiomyocytes transfected
4
dysfunction h9c2
4
ipsc-derived cardiomyocytes
4
q73 human
4
h9c2 expressing
4
repeat q73
4
expressing long
4
human ipsc-derived
4
q77 expression
4

Keyword Occurance

Similar Publications

Establishment of functional epithelial organoids from human lacrimal glands.

Authors:
Sang Yun Jeong Woo Hee Choi Seong Gyeong Jeon Sookon Lee Jong-Moon Park Mira Park Hookeun Lee Helen Lew Jongman Yoo

Stem Cell Res Ther 2021 Apr 21;12(1):247. Epub 2021 Apr 21.

Department of Microbiology and CHA Organoid Research Center, CHA University School of Medicine, 335 Pangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do, 13488, Republic of Korea.

Background: Tear deficiency due to lacrimal gland (LG) dysfunction is one of the major causes of dry eye disease (DED). Therefore, LG stem cell-based therapies have been extensively reported to regenerate injured lacrimal tissue; however, the number of stem cells in the LG tissue is low, and 2D long-term cultivation reduces the differentiation capacity of stem cells. Nevertheless, 3D LG organoids could be an alternative for a DED therapy because it is capable of prolonged growth while maintaining the characteristics of the LG tissue. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Endosomal-lysosomal dysfunctions in Alzheimer's disease: Pathogenesis and therapeutic interventions.

Authors:
Shereen Shi Min Lai Khuen Yen Ng Rhun Yian Koh Kian Chung Chok Soi Moi Chye

Metab Brain Dis 2021 Apr 21. Epub 2021 Apr 21.

Division of Biomedical Science and Biotechnology, School of Health Science, International Medical University, No. 126, Jalan Jalil Perkasa 19, Bukit Jalil, 57000, Kuala Lumpur, Malaysia.

The endosomal-lysosomal system mediates the process of protein degradation through endocytic pathway. This system consists of early endosomes, late endosomes, recycling endosomes and lysosomes. Each component in the endosomal-lysosomal system plays individual crucial role and they work concordantly to ensure protein degradation can be carried out functionally. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Genotype-driven therapeutic developments in Parkinson's disease.

Authors:
Jannik Prasuhn Norbert Brüggemann

Mol Med 2021 Apr 19;27(1):42. Epub 2021 Apr 19.

Department of Neurology, University Medical Center Schleswig-Holstein, Campus Lübeck, Lübeck, Germany.

Background: Remarkable advances have been reached in the understanding of the genetic basis of Parkinson's disease (PD), with the identification of monogenic causes (mPD) and a plethora of gene loci leading to an increased risk for idiopathic PD. The expanding knowledge and subsequent identification of genetic contributions fosters the understanding of molecular mechanisms leading to disease development and progression. Distinct pathways involved in mitochondrial dysfunction, oxidative stress, and lysosomal function have been identified and open a unique window of opportunity for individualized treatment approaches. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

HOPS-associated neurological disorders (HOPSANDs): linking endolysosomal dysfunction to the pathogenesis of dystonia.

Authors:
Edoardo Monfrini Michael Zech Dora Steel Manju A Kurian Juliane Winkelmann Alessio Di Fonzo

Brain 2021 Apr 19. Epub 2021 Apr 19.

Foundation IRCCS Ca' Granda Ospedale Maggiore Policlinico, Neurology Unit, Milan, Italy.

The "homotypic fusion and protein sorting" (HOPS) complex is the structural bridge necessary for the fusion of late endosomes and autophagosomes with lysosomes. Recent publications linked mutations in genes encoding HOPS complex proteins with the etiopathogenesis of inherited dystonias (i.e. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

Metabolic Control of Autoimmunity and Tissue Inflammation in Rheumatoid Arthritis.

Authors:
Jingtao Qiu Bowen Wu Stuart B Goodman Gerald J Berry Jorg J Goronzy Cornelia M Weyand

Front Immunol 2021 2;12:652771. Epub 2021 Apr 2.

Department of Medicine, Stanford University School of Medicine, Stanford, CA, United States.

Like other autoimmune diseases, rheumatoid arthritis (RA) develops in distinct stages, with each phase of disease linked to immune cell dysfunction. HLA class II genes confer the strongest genetic risk to develop RA. They encode for molecules essential in the activation and differentiation of T cells, placing T cells upstream in the immunopathology. Read More

View Article and Full-Text PDF
April 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap